Latest Feature

Gov. Deval Patrick's life sciences legacy

MassDevice.com looks at the life sciences legacy of former Massachusetts Gov. Deval Patrick.

Weight loss: ReShape Medical's Duo balloon system looks to curb obesity

A Q&A with ReShape Medical CEO Richard Thompson on the company's cash pay procedure and how it can make a dent in obese patients.

DeviceTalks podcast: Masimo CEO Kiani

An interview with medtech entrepreneur Joe Kiani, CEO of Masimo Corp. and the founder of the Patient Safety Movement Foundation, recorded at DeviceTalks West Nov. 19, 2014.

HeartFlow wins FDA OK for non-invasive FFR system

The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.

DeviceTalks podcast: B. Braun Medical CEO Caroll Neubauer on device tax, Obamaca

Caroll Neubauer, the CEO of B. Braun Medical, sits down for a wide-ranging interview on the hottest topics facing the medical device industry.

Latest Jobs

Knowledge Library

The secrets to a successful medical device product launch from a public relations perspective  
Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

MassDevice.com +3 | The top 3 medtech stories for May 1, 2015

May 1, 2015 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

ConvaTec makes interim chief Moraviec CEO | Personnel Moves

May 1, 2015 by Brad Perriello

ConvaTec names interim chief executive Paul Moraviec as its permanent CEO.

ConvaTec makes interim chief Moraviec CEO | Personnel Moves

ConvaTec, which is rumored to be exploring a sale, said yesterday that it made its interim CEO, former EMEA president Paul Moraviec, to be its new permanent CEO.

Luxembourg-based ConvaTec, which is owned by private equity firms Avista Capital Partners and Nordic Capital, tapped Moraviec to lead its business in Europe, the Middle East and Africa in 2009.

Greatbatch mulls spinout for Algostim SCS business

May 1, 2015 by Brad Perriello

Greatbatch says it might spin out its Algostim spinal cord stimulation subsidiary as a publicly traded company.

Greatbatch mulls spinout for Algostim SCS business

Profound Medical goes public in reverse merger

May 1, 2015 by Mark Hollmer

Profound Medical becomes a publicly traded with a reverse merger, raising a $24 million private placement to back clinical testing of its prostate cancer ablation device.

Profound Medical goes public in reverse merger

Profound Medical yesterday said it's slated to hit the public markets in Canada after a reverse merger, also revealing a $24 million private placement to fuel clinical trial work.

Hologic raises outlook again after Street-beating Q2

May 1, 2015 by Mark Hollmer

Hologic exceeds expectations again with its fiscal 2nd quarter, beating Wall Street's forecast and raising its outlook for the 2nd time this year.

Hologic raises outlook again after Street-beating Q2

Banned from Medicare, still billing Medicaid

May 1, 2015 by MassDevice

Doctors are still being paid by state Medicaid health insurance programs after being kicked out of another state's Medicaid system or the federal Medicare program.

Banned from Medicare, still billing Medicaid

(Reuters) — A doctor who took kickbacks from a Pennsylvania hospice involved in a multimillion-dollar fraud. An Ohio psychiatrist who billed for treating no-show patients. A Georgia optometrist who claimed he conducted 177 eye exams in 1 day.

Boston Scientific aims for double-digit earnings growth

May 1, 2015 by Brad Perriello

Boston Scientific CEO Mike Mahoney says the company is aiming for double-digit earnings growth each year through 2019.

Boston Scientific aims for double-digit earnings growth

Intarcia raises $225m to fund diabetes trial | Medtech funding for the week of April 27, 2015

May 1, 2015 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Intarcia adds $225m for Type II diabetes trial; Gynesonics raises $3m for VizAblate fibroid device; Lombard Medical takes out $26m loan for Aorfix stent graft; Alliqua prices $30m offering; Contego Medical raises $6m for embolic filter tech

Intarcia adds $225m for Type II diabetes trial

April 28, 2015 by Brad Perriello